Autopsy report · NCT04855175

Evaluation of Cranioplasty Using Native Bone Autograft Versus Synthetic Bone Allograft

“Sponsor termination”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months after it had already started.
• Ran for about 1 year before it stopped.
• 1 participant enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

LifeBridge Health

Sponsor type

University, hospital or other

Conditions

Surgical Procedure, Unspecified

Interventions

Synthetic Bone Allograft (ClearFit); Autograft

Participants

1

Sites

1

Countries

United States

Trials that died the same way

• Pomalidomide With Melphalan and Dexamethasone for Untreated Systemic AL Amyloidosis
  “Sponsor requested termination” (95% match in meaning)
• RibFix Advantage™ Post-Market Follow-Up
  “Sponsor Terminated” (90% match in meaning)
• ALD-101 Adjuvant Therapy of Unrelated Umbilical Cord Blood Transfusion (UCBT) in Patients With Inherited Metabolic Diseases
  “Terminated - Sponsor Decision” (90% match in meaning)
• A Randomized Study of Epigenetic Priming Using Decitabine With Front Line Induction Chemotherapy Compared With Immediate Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
  “Terminated by Sponsor” (89% match in meaning)
• A Clinical Study of IMP4297 Capsule (JS109) Combined With Irinotecan in the Treatment of Advanced Malignant Solid Tumors
  “The sponsor voluntarily requested termination” (88% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.